exemestane peptide is used to treat early breast cancer in women who have experienced menopause - 依西美坦 Oxy reduces cell viability, impairs DNA synthesis and induces apoptosis Understanding Exemestane: An Aromatase Inhibitor for Breast Cancer Treatment

依西美坦 Exemestane is a crucial medication in the fight against breast cancer, particularly for postmenopausal women. It belongs to a class of drugs known as aromatase inhibitors, and its primary function is to significantly reduce the body's production of estrogen.NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studyingexemestane. Estrogen can fuel the growth of hormone receptor-positive breast cancer cells, so by lowering estrogen levels, exemestane plays a vital role in managing and treating this disease.

Mechanism of Action: How Exemestane Works

Exemestane, also known by the brand name Aromasin, functions by irreversibly inhibiting the enzyme aromatase. Aromatase is a key enzyme responsible for converting androgens into estrogens in both pre-menopausal and post-menopausal women. In postmenopausal women, the ovaries cease functioning, and the adrenal glands become the primary source of androgens, which are then converted to estrogens by aromatase in peripheral tissues. Exemestane acts as a steroid, binding to and inactivating aromatase. This process, known as aromatase inactivation, effectively blocks the biosynthesis of estrogen, thereby lowering circulating estrogen levels. Studies have shown exemestane inhibits human placental and rat ovarian aromatase with IC50 values of 30 nM and 40 nM, respectively. Its mechanism involves acting as a false substrate for the aromatase enzyme, leading to irreversible inhibition.

Therapeutic Applications and Patient Populations

Exemestane is a medication used to treat breast cancer, specifically both early and advanced forms. It is prescribed to women who have already experienced menopause, meaning their monthly menstrual periods have ceased (postmenopausal women). The drug is often used as an adjuvant therapy after initial treatments or for advanced breast cancerClinical Differences among the Aromatase Inhibitors1. For instance, exemestane therapy after two to three years of tamoxifen therapy has shown to significantly improve disease-free survival compared to completing the standard five years of tamoxifen. Furthermore, clinical trials are investigating the use of exemestane in combination with other therapies, such as triptorelin and tamoxifen, to combat breast cancer by blocking estrogen's use. Exemestane is also being studied for its antiproliferative effects, with research indicating that treatment with exemestane led to a significant reduction in tumor cell growth and perturbation of the cell cycle in certain cancer cell lines.

Dosage and Administration

Exemestane is typically administered orally.Exemestane (Aromasin): Uses, Side Effects, Alternatives & ... The standard dosage for treating breast cancer is 25mg once daily. The medication is often supplied in tablet form, with common packaging containing 30 tablets. It is crucial for patients to take exemestane exactly as prescribed by their healthcare providerExemestane (Aromasin): What to Expect, Side Effects, and .... While specific detailed dosage information is best obtained from a medical professional, general guidance for exemestane (oral route) side effects & dosage is readily available through trusted medical resources.

Side Effects and Precautions

As with any medication, exemestane can cause side effects. Common side effects may include hot flashes, fatigue, joint pain, headache, and nausea. More serious side effects can occur, and it is essential for patients to report any unusual or severe symptoms to their doctor. People who are allergic to Exemestane or any component of its formulation should not take the medication.Clinical Trials Using Exemestane - NCI Patients should discuss their complete medical history, including any pre-existing conditions and other medications they are taking, with their physician before starting exemestane. Notably, exemestane results in increases in markers of bone formation and resorption, while decreases are observed with tamoxifen, suggesting a potential impact on bone health that warrants monitoring.AROMASIN® (exemestane) Clinical Pharmacology Patient ...

Exemestane vs. Other Aromatase Inhibitors

Exemestane is part of a group of drugs known as aromatase inhibitors, which include others like Letrozole. While all these medications work by reducing estrogen levels, there can be clinical differences among them2025年8月1日—Exemestaneis used to treat early and advanced breast cancerin women who have already stopped menstruating (postmenopausal).. Identifying specific clinical differences among the aromatase inhibitors is an ongoing area of research and clinical practice. The choice of which aromatase inhibitor to use often depends on the individual patient's situation, including the stage of breast cancer, other medical conditions, and tolerance to specific medications.2025年12月14日—Exemestane is an aromatase inactivator, which works to decrease the overall levels of estrogen in your body. In females who have gone through ...

Research and Future Directions

Ongoing research continues to explore the full potential of exemestane. Clinical trials supported by institutions like the National Cancer Institute (NCI) are testing new and more effective ways to treat cancer, including those involving exemestane.Exemestane (Aromasin) | Cancer information Studies are also investigating derivatives of exemestane, such as Oxymestane-D1, to understand their potential therapeutic properties, including their ability to reduce cell viability, impair DNA synthesis, and induce apoptosisExemestane is an aromatase inhibitor, inhibits human placental and rat ovarian aromatase with IC50 of 30 nM and 40 nM, respectively.. The drug's mechanism as an antineoplastic, estrogen biosynthesis inhibitor highlights its significance in cancer therapy, particularly for breast cancer.

In summary, exemestane is a vital hormonal therapy drug that functions as a potent aromatase inhibitor依西美坦Exemestane (Aromasin). By effectively lowering estrogen levels, it plays a critical role in treating and managing breast cancer in postmenopausal women.作者：D Stoppoloni·2011·被引用次数：15—Treatment of MM cells withexemestane led to significant reduction of tumor cell growth, perturbation of cell cycle, caspase activation, poly(ADP-ribose) ... Understanding its mechanism, applications, and potential side effects empowers patients and healthcare providers in making informed treatment decisions.